ASEAN MEDICAL DEVICE MARKET ACCESS
Medical Device Registration
Across Southeast Asia
ASEAN provides a common regulatory foundation for medical devices, but market access remains country-specific. MediPass helps manufacturers translate one regional strategy into practical registration, local representation and ongoing compliance across Singapore, Malaysia, Thailand, Vietnam and Indonesia.
ONE REGIONAL FRAMEWORK
Risk Classification
ASEAN CSDT
Essential Principles
Post-Market Controls
FIVE NATIONAL PATHWAYS
THE ASEAN FRAMEWORK
Harmonised framework.
National approvals.
The ASEAN Medical Device Directive (AMDD) establishes common regulatory principles for medical devices across ASEAN, including risk classification, essential principles, common dossier structure and post-market controls. Each member state nevertheless retains its own regulatory authority and national market-access process.
Risk-Based Classification
Common ASEAN principles support risk-based classification of medical devices and IVDs.
ASEAN CSDT
A common dossier structure helps manufacturers organise core technical documentation for regional submissions.
Essential Principles
Safety and performance requirements provide a common regulatory foundation.
Post-Market Controls
Vigilance, adverse-event reporting and corrective-action obligations continue after market entry.
AMDD does not create a single ASEAN medical device approval.
Each member state retains its own regulatory authority, application process, local requirements and market authorisation.
COUNTRY-SPECIFIC EXECUTION
Five markets.
Five national pathways.
Singapore
HSA
- Class A notification / exemption framework
- Class B–D registration
- Full, abridged, expedited and immediate evaluation routes
Malaysia
MDA
- Class A–D framework
- Conformity assessment, where applicable, and product registration
- Applications through MeDC@St
Thailand
Thai FDA
- Class 1 listing
- Class 2–3 notification
- Class 4 licensing
- Full, abridged and reliance pathways where applicable
Vietnam
Ministry of Health / IMDA
- Class A–B declaration pathway
- Class C–D circulation registration
- Vietnam-specific local and dossier requirements
Indonesia
Ministry of Health
- Class A–D risk framework
- Product marketing authorisation
- Local regulatory and distribution requirements
REGIONAL PLANNING
What can be shared —
and what must be localised.
REGIONAL FOUNDATION
- Device description & intended purpose
- Risk classification principles
- CSDT-style technical documentation
- Safety & performance evidence
- Quality-system evidence
- Post-market planning
COUNTRY-SPECIFIC EXECUTION
- Regulatory authority & submission platform
- Local registration holder / authorised entity
- Registration or reliance pathway
- Country-specific labelling
- Establishment / importer requirements
- Fees, review process and lifecycle obligations
HOW MEDIPASS SUPPORTS YOU
From one dossier to a coordinated ASEAN strategy.
01
Define the Regulatory Scope
Confirm intended purpose, classification, configurations and target markets.
02
Map the Regional Dossier
Identify the common technical evidence that can support multiple ASEAN submissions.
03
Localise Each Market Pathway
Address country-specific registration, local representation, labelling and establishment requirements.
04
Maintain Market Access
Coordinate renewals, changes, authority correspondence and post-market obligations.
REGULATORY SUPPORT
Classification & GroupingProduct RegistrationLocal RepresentationEstablishment LicensingImport & Market AccessPost-Market & Change Management
COMMON QUESTIONS
Planning ASEAN medical device registration.
Does AMDD provide one registration for all ASEAN countries?
No. AMDD harmonises core regulatory principles and documentation, but each ASEAN member state maintains its own market-authorisation process and national requirements.
Can one technical dossier be used across several ASEAN markets?
A well-prepared core dossier can support a regional strategy, particularly where ASEAN CSDT principles are used. Country-specific documents, local representation, labelling and regulatory pathways still need to be addressed individually.
Do overseas manufacturers need a local regulatory partner?
Yes. Overseas manufacturers and brand owners need an eligible local regulatory entity in each target market. The overseas company can remain the Product Owner, while the local entity acts as the registrant, authorised representative, importer or market-authorisation holder, depending on the country. MediPass can coordinate this local representation across Singapore, Malaysia, Thailand, Vietnam and Indonesia.
PLAN YOUR ASEAN MARKET ENTRY
One regional plan.
Five country-specific pathways.
Tell us about your device, current approvals and target markets. We’ll help identify the practical regulatory route across Southeast Asia.
MediPass
Regulatory strategy and market access support for medical device and IVD manufacturers in Southeast Asia.
Contact
© 2026 MediPass. All rights reserved.